skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Textbook of gynecology
Textbook of gynecology
Material Type:
Livro 		Adicionar ao Meu Espaço

Textbook of gynecology

Larry J Copeland; John F Jarrell

Philadelphia Saunders c2000

Localização: HU - Hospital Universitário    (WP140 T355 2.ed. )(Acessar)

2
Textbook of gynecology
Textbook of gynecology
Material Type:
Livro 		Adicionar ao Meu Espaço

Textbook of gynecology

Larry J Copeland; John F Jarrell; James A McGregor

Philadelphia W. B. Saunders 1993

Localização: FM - Fac. Medicina    (WP140 C788t 1993 ex.2 )(Acessar)

3
Textbook of gynecology
Textbook of gynecology
Material Type:
Livro 		Adicionar ao Meu Espaço

Textbook of gynecology

Larry J Copeland; John F Jarrell; James A McGregor

Philadelphia W.B. Saunders c1993

Localização: HU - Hospital Universitário    (WP100 C782t )(Acessar)

4
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Tewari, Krishnansu S ; Burger, Robert A ; Enserro, Danielle ; Norquist, Barbara M ; Swisher, Elizabeth M ; Brady, Mark F ; Bookman, Michael A ; Fleming, Gini F ; Huang, Helen ; Homesley, Howard D ; Fowler, Jeffrey M ; Greer, Benjamin E ; Boente, Matthew ; Liang, Sharon X ; Ye, Chenglin ; Bais, Carlos ; Randall, Leslie M ; Chan, John K ; Ferriss, J Stuart ; Coleman, Robert L ; Aghajanian, Carol ; Herzog, Thomas J ; DiSaia, Philip J ; Copeland, Larry J ; Mannel, Robert S ; Birrer, Michael J ; Monk, Bradley J

Journal of clinical oncology, 2019-09, Vol.37 (26), p.2317-2328 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Armstrong, Deborah K ; Bundy, Brian ; Wenzel, Lari ; Huang, Helen Q ; Baergen, Rebecca ; Lele, Shashikant ; Copeland, Larry J ; Walker, Joan L ; Burger, Robert A

The New England journal of medicine, 2006-01, Vol.354 (1), p.34-43 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
6
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?

Smith, Blair ; McCann, Georgia A ; Phillips, Gary ; Backes, Floor J ; O'Malley, David M ; Cohn, David E ; Fowler, Jeffrey M ; Copeland, Larry J ; Salani, Ritu

Gynecologic oncology, 2017-02, Vol.144 (2), p.290-293 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations

Barrington, David A. ; Felix, Ashley S. ; Owda, Rieham ; Suarez, Adrian A. ; Cohen, David W. ; Senter, Leigha ; Copeland, Larry J. ; Fowler, Jeffrey M. ; Backes, Floor J. ; Cohn, David E. ; Bixel, Kristin L. ; O'Malley, David M. ; Salani, Ritu ; Cosgrove, Casey M.

Surgical oncology, 2020-09, Vol.34, p.40-45 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Mirza, Mansoor R. ; Chase, Dana M. ; Slomovitz, Brian M. ; dePont Christensen, René ; Novák, Zoltán ; Black, Destin ; Gilbert, Lucy ; Sharma, Sudarshan ; Valabrega, Giorgio ; Landrum, Lisa M. ; Hanker, Lars C. ; Stuckey, Ashley ; Boere, Ingrid ; Gold, Michael A. ; Auranen, Annika ; Pothuri, Bhavana ; Cibula, David ; McCourt, Carolyn ; Raspagliesi, Francesco ; Shahin, Mark S. ; Gill, Sarah E. ; Monk, Bradley J. ; Buscema, Joseph ; Herzog, Thomas J. ; Copeland, Larry J. ; Tian, Min ; He, Zangdong ; Stevens, Shadi ; Zografos, Eleftherios ; Coleman, Robert L. ; Powell, Matthew A.

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Piver, Rachael N. ; Wagner, Vincent M. ; Levine, Monica D. ; Backes, Floor J. ; Chambers, Laura J. ; Cohn, David E. ; Copeland, Larry J. ; Cosgrove, Casey M. ; Nagel, Christa I. ; O'Malley, David M. ; Bixel, Kristin L.

Gynecologic oncology reports, 2023-04, Vol.46, p.101156-101156, Article 101156 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Tewari, Krishnansu S ; Sill, Michael W ; Penson, Richard T ; Huang, Helen ; Ramondetta, Lois M ; Landrum, Lisa M ; Oaknin, Ana ; Reid, Thomas J ; Leitao, Mario M ; Michael, Helen E ; DiSaia, Philip J ; Copeland, Larry J ; Creasman, William T ; Stehman, Frederick B ; Brady, Mark F ; Burger, Robert A ; Thigpen, J Tate ; Birrer, Michael J ; Waggoner, Steven E ; Moore, David H ; Look, Katherine Y ; Koh, Wui-Jin ; Monk, Bradley J

The Lancet (British edition), 2017-10, Vol.390 (10103), p.1654-1663 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (244)
  2. Book Chapters  (13)
  3. Livros  (4)
  4. Reports  (1)
  5. Anais de Congresso  (1)
  6. Mais opções open sub menu

Autor/Criador 

  1. Copeland, L  (3)
  2. Jarrell, J  (3)
  3. McGregor, J  (2)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1987  (39)
  2. 1987Até1995  (34)
  3. 1996Até2004  (45)
  4. 2005Até2013  (54)
  5. Após 2013  (91)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Copeland, L
  2. Jarrell, J
  3. McGregor, J

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Female
  5. Obstetrics & Gynecology

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.